Document Detail

Periconceptional folic acid use: Still room to improve.
MedLine Citation:
PMID:  22246989     Owner:  NLM     Status:  Publisher    
BACKGROUND: Folic acid use before and during pregnancy prevents neural tube defects. Since 1995, six surveys have been carried out among pregnant women to measure their knowledge and use of folic acid. The results of the most recent survey in 2009 will be discussed and compared with earlier surveys.: METHODS: Pregnant women in the Northern Netherlands were asked to fill out a questionnaire when visiting their midwife or gynecologist.: RESULTS: Of the 515 participating women, 87.0% knew of folic acid before they became pregnant. Of all respondents, 51.6% reported to have used folic acid during the entire recommended period. Multivariate analysis showed that planned pregnancy (odds ratio [OR], 7.1; 95% confidence interval [CI], 2.4-20.7), smoking (OR, 0.2; 95% CI, 0.1-0.7), folic acid use during a former pregnancy (OR, 22.6; 95% CI, 5.5-92.8) and the number of previous children (per child OR, 0.5; 95% CI, 0.3-0.9) were predicting factors for the recommended use of folic acid; 89.9% of women were sufficiently knowledgeable to start to use folic acid before pregnancy.: CONCLUSIONS: The knowledge about folic acid has declined over recent years, and the use during the recommended period did not improve since the survey of 2005. Based on this survey, there is still room for improvement in the knowledge and actual use of folic acid before pregnancy. Attention to these aspects should focus on younger, low-educated women and should include information about family planning and contraceptives. Birth Defects Research (Part A) 2012. © 2012 Wiley Periodicals, Inc.
Priscilla A Zetstra-van der Woude; Hermien E K de Walle; Lolkje T W de Jong-van den Berg
Related Documents :
9711249 - 1 beta-methyl-2(5-substituted pyrrolidin-3-ylthio)carbapenems. 1. synthesis and antibac...
3279209 - Synthesis and anticandidal properties of polyoxin l analogues containing alpha-amino fa...
23105609 - Comparative analysis of rbc membrane fatty acids, proteins and glycophorin in patients ...
576619 - Alkaloids of vinca rosea l. (catharanthus roseus g. don). 38. 4'-dehydrated derivatives.
3700459 - New derivatives of cnc-amino acids and -oligopeptides: experimental antitumor activity.
19199479 - Structural requirements for a lipoamino acid in modulating the anticonvulsant activitie...
2800929 - Ovarian aromatase activity in scorbutic mutant rats unable to synthesize ascorbic acid.
7161849 - Toxicological significance of pesticide conjugates.
102639 - Cell wall assembly in bacillus subtilis: location of wall material incorporated during ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-13
Journal Detail:
Title:  Birth defects research. Part A, Clinical and molecular teratology     Volume:  -     ISSN:  1542-0760     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101155107     Medline TA:  Birth Defects Res A Clin Mol Teratol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Unit of Pharmacoepidemiology and Pharmacoeconomy, Department of Pharmacy, University of Groningen, Groningen, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  N-myc downstream regulated gene 1 modulates Wnt-?-catenin signalling and pleiotropically suppresses ...
Next Document:  On the fluid-tissue contrast behavior of high-resolution steady-state sequences.